Top compounds associated with response to CT47A2


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.03
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.03
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.075 0.03
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.03
mRNA SB-525334 CTRPv2 pan-cancer AAC -0.076 0.03
mRNA Sunitinib CTRPv2 pan-cancer AAC -0.071 0.03
mRNA neratinib CTRPv2 pan-cancer AAC -0.072 0.04
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC -0.069 0.04
mRNA barasertib CTRPv2 pan-cancer AAC -0.065 0.04
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.07 0.04
Download CSV